Screener
ClearPoint Neuro CLPT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Operating lease, right-of-use assets | 13,088 | 8,430 |
| Goodwill | 7,472 | 7,472 |
| Intangible assets, net | 13,419 | 13,922 |
| Other assets | 1,646 | 1,702 |
| Total assets | $93,416 | $97,747 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,330 | $1,256 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's deferred tax assets and other non-current assets?
- ClearPoint Neuro (CLPT) reported deferred tax assets and other non-current assets of $1.65M in Q1 2026.
- How has ClearPoint Neuro's deferred tax assets and other non-current assets changed year-over-year?
- ClearPoint Neuro's deferred tax assets and other non-current assets increased by 1012.2% year-over-year, from $148K to $1.65M.
- What is the long-term trend for ClearPoint Neuro's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), ClearPoint Neuro's deferred tax assets and other non-current assets has grown at a 96.6% compound annual growth rate (CAGR), from $58K to $1.7M.
Ask your AI about ClearPoint Neuro's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude